Skip to Main Content

Author Details

Kimberly C Lin
University of California san francisco
2010
19
16
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35395091The Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance Mechanisms.Mol Cancer Ther2022
35613278The Hippo pathway mediates Semaphorin signaling.Sci Adv2022
33311646Publisher Correction: Heat stress activates YAP/TAZ to induce the heat shock transcriptome.Nat Cell Biol2021
32396613Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes.Blood Adv2020
30018319Author Correction: Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.Nat Cell Biol2018
30135582RAP2 mediates mechanoresponses of the Hippo pathway.Nature2018
29802201The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell.J Biol Chem2018
28752853Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.Nat Cell Biol2017
28417999A tiling-deletion-based genetic screen for cis-regulatory element identification in mammalian cells.Nat Methods2017
28490572Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis.Blood2017
28964625Regulation of the Hippo Pathway Transcription Factor TEAD.Trends Biochem Sci2017
27912098Characterization of Hippo Pathway Components by Gene Inactivation.Mol Cell2016
25847190Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 "Gatekeeper" F691L Mutation with PLX3397.Cancer Discov2015
26276632Alternative Wnt Signaling Activates YAP/TAZ.Cell2015
26108694FLT3 D835 mutations confer differential resistance to type II FLT3 inhibitors.Leukemia2015
24623852Crenolanib is a selective type I pan-FLT3 inhibitor.Proc Natl Acad Sci U S A2014
25531068Overcoming myelosuppression due to synthetic lethal toxicity for FLT3-targeted acute myeloid leukemia therapy.Elife2014
23430109Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD.Blood2013
20827424The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN Circuit.Genes Cancer2010
  • 1 - 19 of 19

Recommended Authors

Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Career Start Year 2017
Number of shared co-authors 0
Alexandre Rosa Campos
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2015
Number of shared co-authors 0
Nadia Arang
Moores Cancer Center, University of California San Diego
Career Start Year 2014
Number of shared co-authors 0
Victor Olivas
University of California san francisco
Career Start Year 2012
Number of shared co-authors 1
Helong Zhao
Versiti Blood Research Institute and Medical College of Wisconsin
Career Start Year 2012
Number of shared co-authors 1
Evangelos Pazarentzos
University of California san francisco
Career Start Year 2011
Number of shared co-authors 1
Luping Lin
Incyte Research Institute, Incyte Corporation
Career Start Year 2010
Number of shared co-authors 1
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Guo Chen
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 0
Helen He Zhu
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Shweta Joshi
Moores Cancer Center, University of California
Career Start Year 2007
Number of shared co-authors 0
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Career Start Year 2007
Number of shared co-authors 0
Jacob R Haling
Genomics Institute of the Novartis Research Foundation
Career Start Year 2007
Number of shared co-authors 0
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 2
Jinbo Yang
School of Medicine and Pharmacy, Ocean University of China
Career Start Year 2003
Number of shared co-authors 0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Yong Jae Shin
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 0
Hye Jin You
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Stephane Angers
Department of Pharmaceutical Sciences, University of Toronto
Career Start Year 1999
Number of shared co-authors 0
Chandra C Ghosh
The Wistar Institute
Career Start Year 1999
Number of shared co-authors 0
Monika A Davare
Oregon Health Sciences University
Career Start Year 1998
Number of shared co-authors 0
Michael A White
University of Georgia
Career Start Year 1994
Number of shared co-authors 1
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 0
Aykut Uren
Georgetown University Medical Center
Career Start Year 1991
Number of shared co-authors 0
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 0
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 1
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Career Start Year 1984
Number of shared co-authors 5
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 0
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 5

Collaborators

Kun-Liang Guan
University of California San Diego
Co-authored papers 10
Zhipeng Meng
University of Miami Miller School of Medicine
Co-authored papers 8
Catherine C Smith
University of California San Francisco
Co-authored papers 7
Neil P Shah
University of California San Francisco
Co-authored papers 6
Steven W Plouffe
University of California
Co-authored papers 6
Hyun Woo Park
College of Life Science and Biotechnology, Yonsei University
Co-authored papers 5
Toshiro Moroishi
Kumamoto University
Co-authored papers 5
Elisabeth A Lasater
University of California san francisco
Co-authored papers 4
Yunjiang Qiu
Ludwig Institute for Cancer Research, University of California
Co-authored papers 4
Bing Ren
Center for Epigenomics, University of California San Diego
Co-authored papers 4
Yarui Diao
Duke University Medical Center
Co-authored papers 3
Jiahuai Han
Co-authored papers 2
Adam J Engler
University of California
Co-authored papers 2
Fa-Xing Yu
Institute of Pediatrics, Children's Hospital of Fudan University
Co-authored papers 2
Audrey W Hong
Stanford University School of Medicine
Co-authored papers 2
Evan Massi
University of California san francisco
Co-authored papers 2
Zhen Ye
Ludwig Institute for Cancer Research, University of California San Diego
Co-authored papers 2
Cun-Yu Wang
University of California, Los Angeles (university of california los angeles)
Co-authored papers 2
Cao Fang
University of California
Co-authored papers 2
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 1
Aditya Kumar
Rice University, University of California San Diego
Co-authored papers 1
Ali Bashir
Google Accelerated Science Team, Google Inc
Co-authored papers 1
Hui Huang
Co-authored papers 1
Yin Shen
Wenzhou Medical University
Co-authored papers 1
Jesse K Placone
University of California San Diego
Co-authored papers 1
Benjamin Yeoman
University of California
Co-authored papers 1
John Kuriyan
University of California berkeley
Co-authored papers 1
Kuei-Chun Wang
Arizona State University
Co-authored papers 1
Jerald P Radich
Fred Hutchinson Cancer Center
Co-authored papers 1
Shicong Lu
University of California San Diego
Co-authored papers 1
Release 1.2